Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT)
Clinical trial NCT03298412 · TERMINATED
Trial details
- NCT number
- NCT03298412
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-23
- Primary completion
- 2019-09-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.